SCHEMBL31248472

SCHEMBL31248472

CC[C@H](C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 6/20 0.63
▸ CASP1 P29466 4/20 0.63
▸ CASP9 P55211 4/20 0.63
▸ CASP4 P49662 2/20 0.63
▸ CASP5 P51878 2/20 0.63
▸ CASP6 P55212 2/20 0.63
▸ CASP8 Q14790 2/20 0.63
▸ CASP10 Q92851 2/20 0.63
▸ CASP7 P55210 2/20 0.61
▸ CTSB P07858 2/20 0.58
▸ CTSL P07711 1/20 0.58
▸ CTSS P25774 1/20 0.58
▸ MEN1 O00255 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ LMNA P02545 1/20 0.56
▸ PSMB5 P28074 1/20 0.52
▸ ENPEP Q07075 5/20 0.52
▸ FOLH1 Q04609 1/20 0.51
▸ MME P08473 2/20 0.51
▸ ECE1 P42892 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30541131 0.95 CASP3 (0.61) CASP3CASP1CASP9CASP4CASP5
SCHEMBL6669609 0.93 CTSB (0.63) CASP3CASP1CASP9CASP4CASP5
SCHEMBL29362585 0.88 CASP3 (0.76) CASP3CASP1CASP9CASP4CASP5
SCHEMBL3490826 0.87 CASP3 (0.73) CASP3CASP1CASP9CASP4CASP5
SCHEMBL23613622 0.87 CASP3 (0.56) CASP3CASP1CASP9CASP4CASP5
SCHEMBL3317466 0.87 CASP3 (0.62) CASP3CASP1CASP9CASP4CASP5
SCHEMBL2040978 0.86 CASP3 (0.57) CASP3CASP1CASP9CASP4CASP5
SCHEMBL2038060 0.86 CASP3 (0.63) CASP3CASP1CASP9CASP4CASP5
SCHEMBL18114521 0.85 MEN1 (0.59) CASP3CASP1CASP9CASP4CASP5
SCHEMBL18114520 0.85 MEN1 (0.59) CASP3CASP1CASP9CASP4CASP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4719370-A1 COMPOUNDS FOR USE IN ORGAN PRESERVATION AND ORGAN TRANSPLANTATION Abrexa Pharmaceuticals, Inc. (US) 2026-04-08 — — EP disclosed
US-20260076926-A1 COMPOUNDS FOR USE IN ORGAN PRESERVATION AND ORGAN TRANSPLANTATION ABREXA PHARMACEUTICALS, INC. (US) 2026-03-19 — — US disclosed
WO-2024249415-A1 COMPOUNDS FOR USE IN ORGAN PRESERVATION AND ORGAN TRANSPLANTATION ABREXA PHARMACEUTICALS, INC. (US) 2024-12-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260076926-A1 COMPOUNDS FOR USE IN ORGAN PRESERVATION AND ORGAN TRANSPLANTATION CASP9, CASP3, CASP10 CASP3 2/4885CASP1 214/4885CASP9 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback